|
FY2025
12 months to Jan 3, 2026
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by (used in) operating activities | |||||
| Depreciation and amortization | |||||
| Right-of-use asset reduction | |||||
| (Gain) loss on sale of property and equipment | |||||
| Equity-based compensation expense | |||||
| Deferred income taxes | |||||
| Inventory write-down | |||||
| Impairment | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Receipts on notes receivable | |||||
| Proceeds from the settlement of net investment hedges | |||||
| Payments for net investment hedge | |||||
| Proceeds from acquisition working capital adjustment | |||||
| Payments to acquire businesses, net of cash acquired | |||||
| Proceeds from sale of property and equipment | |||||
| Purchases of property and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Repurchase of common stock | |||||
| Borrowings on line of credit | |||||
| Payments on line of credit | |||||
| Payments related to tax withholding for net-share settled equity awards | |||||
| Distributions to redeemable noncontrolling interest | |||||
| Payments for contingent consideration | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other assets | |||||
| Total cash, cash equivalents, and restricted cash | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Income taxes | |||||
| Income tax refund | |||||
| Non-cash investing and financing activities: | |||||
| Right-of-use assets obtained in exchange for lease obligations | |||||
| Net working capital adjustment receivable | |||||
| Accrued purchases of property and equipment | |||||
| Contingent consideration given to acquire businesses | |||||
| Accrued excise tax for repurchase of common stock | |||||
Loading...